Imatinib 400mg Capsules (3 x 10) PL 36390/0180 : Company-led Drug Alert
Yes – this has been recalled
- The problem
- Cipla (EU) Limited has informed MHRA that there is an error on the Patient Information Leaflet (PIL) for the above product: the dosage information for the indication CML is incorrect
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA)
Official notice ↗
Product information
CLDA number
CLDA (18)A/08
MDR number
MDR 43-09/18
Company name
Cipla (EU) Ltd
Product description
Imatinib 400mg Capsules (3 x 10) PL 36390/0180
Batch number/expiry
| Batch Number | Expiry Date |
| GJ80583 | April 2020 |
Brief description of the problem
Cipla (EU) Limited has informed MHRA that there is an error on the Patient Information Leaflet (PIL) for the above product: the dosage information for the indication CML is incorrect
Action
Pharmacists are asked to remove the defective PIL from affected cartons before dispensing and provide a copy of the correct PIL
Please ensure that existing patients are taking the correct dose and provide a copy of the correct PIL if necessary.
Company contact for medical information enquiries:
Cipla (EU) Ltd
Tel: 07826544512 or 07876612672
Email: Sabrina.Ebu@Cipla.com or Prashant.Shirode@Cipla.com
Updated 21 September 2018. This page summarises an official notice. Details can change – always follow the official notice.